HAEMONETICS CORP (HAE) — insider trading
Health Care · NYSE
HAEMONETICS CORP (HAE) has 19 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase among the most recent 19 (latest 2026-06-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Miller Laurie A. | Officer (SVP, Human Resources) | Shares withheld for taxes / exercise cost | 313 | $71.28 | $22.3K | Form 4 |
| 2026-06-05 | Maunsell Farris Maryanne | Officer (VP, Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 259 | $71.28 | $18.5K | Form 4 |
| 2026-05-15 | Simon, Christopher | Director, Officer (President & CEO) | Grant / award / vesting | 78,344 | — | — | Form 4 |
| 2026-05-15 | Simon, Christopher | Director, Officer (President & CEO) | Shares withheld for taxes / exercise cost | 9,681 | $56.29 | $544.9K | Form 4 |
| 2026-05-15 | Miller Laurie A. | Officer (SVP, Human Resources) | Grant / award / vesting | 13,323 | — | — | Form 4 |
| 2026-05-15 | Miller Laurie A. | Officer (SVP, Human Resources) | Shares withheld for taxes / exercise cost | 948 | $56.29 | $53.4K | Form 4 |
| 2026-05-15 | Galvin Roy | Officer (EVP, Chief Commercial Officer) | Grant / award / vesting | 27,535 | — | — | Form 4 |
| 2026-05-15 | Galvin Roy | Officer (EVP, Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 879 | $56.29 | $49.5K | Form 4 |
| 2026-05-15 | Maunsell Farris Maryanne | Officer (VP, Chief Accounting Officer) | Grant / award / vesting | 2,220 | — | — | Form 4 |
| 2026-05-15 | Maunsell Farris Maryanne | Officer (VP, Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 197 | $56.29 | $11.1K | Form 4 |
| 2026-05-15 | DArecca James | Officer (EVP, Chief Financial Officer) | Grant / award / vesting | 29,312 | — | — | Form 4 |
| 2026-05-15 | DArecca James | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 2,505 | $56.29 | $141.0K | Form 4 |
| 2026-05-15 | Chan Frank | Officer (EVP, Chief Operating Officer) | Grant / award / vesting | 27,535 | — | — | Form 4 |
| 2026-05-15 | Chan Frank | Officer (EVP, Chief Operating Officer) | Shares withheld for taxes / exercise cost | 546 | $56.29 | $30.7K | Form 4 |
| 2026-05-15 | Basil Michelle L | Officer (EVP and General Counsel) | Grant / award / vesting | 28,424 | — | — | Form 4 |
| 2026-05-15 | Basil Michelle L | Officer (EVP and General Counsel) | Shares withheld for taxes / exercise cost | 2,913 | $56.29 | $164.0K | Form 4 |
| 2026-05-01 | DArecca James | Officer (EVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 655 | $59.26 | $38.8K | Form 4 |
| 2025-11-10 | KROLL MARK W | Director | Open-market purchase | 1,400 | $70.56 | $98.8K | Form 4 |
| 2025-10-31 | Galvin Roy | Officer (EVP, Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 145 | $50.01 | $7.3K | Form 4 |
Ask the chat about HAE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HAEMONETICS CORP (HAE).
Last updated 2026-06-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.